Skip to main content
x

Recent articles

More problems for BioNTech & Roche’s neoantigen shot

Autogene cevumeran goes on hold in adjuvant bladder cancer.

Arvinas leader departs under a Pfizer-shaped cloud

Weeks after criticising the group’s big pharma partner, John Houston is on his way out.

When two antigens are better than one

Multispecifics newly into the clinic include Car-Ts from Essen and Unicar.

Early validation for in vivo Car-T

ESO-T01 delivers its first four multiple myeloma case reports.

Concentra picks up a new Cargo

The Tang Capital Partners vehicle has already acquired IGM, Elevation and Kronos.

Licensing analysis: big deals bolster biotech

PD-(L)1 x VEGF bispecifics prove a big draw.